CAG repeats determine brain atrophy in spinocerebellar ataxia 17: A VBM study

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Reetz, Kathrin ^a,b,c   Kleinman, Alexandra ^a,b,c   Klein, Christine ^d   Lencer, Rebekka ^d   Zuehlke, Christine ^d   Brockmann, Kathrin ^e   Rolfs, Arndt ^e   Binkofski, Ferdinand ^f  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

^c JARA Jülich Aachen Research Alliance Future Information Technology   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

^e UNIVERSITY OF ROSTOCK   (Germany)

^f RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TATA BINDING PROTEIN;

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CAG REPEAT; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE PREDISPOSITION; FEMALE; GRAY MATTER; HEREDITY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SPINOCEREBELLAR DEGENERATION; SPINOCEREBELLAR DEGENERATION 17; VOXEL BASED MORPHOMETRY; ATROPHY; BRAIN; CASE CONTROL STUDY; GENETICS; METABOLISM; MIDDLE AGED; NERVE DEGENERATION; ONSET AGE; PATHOLOGY; TRINUCLEOTIDE REPEAT;

ADULT; AGE OF ONSET; ATROPHY; BRAIN; CASE-CONTROL STUDIES; CEREBELLUM; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE DEGENERATION; SPINOCEREBELLAR ATAXIAS; TRINUCLEOTIDE REPEATS;

EID: 79251631939     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015125     Document Type: Article

References (23)

1. Bech S, Petersen T, Norremolle A, Gjedde A, Ehlers L, et al. (2010) Huntington's disease-like and ataxia syndromes: identification of a family with a de novo SCA17/TBP mutation. Parkinsonism Relat Disord 16: 12-15.
2. Nakamura K, Jeong SY, Uchihara T, Anno M, Nagashima K, et al. (2001) SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 10: 1441-1448.
3. Bauer P, Laccone F, Rolfs A, Wullner U, Bosch S, et al. (2004) Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington's diseaselike phenotype. J Med Genet 41: 230-232.
4. De Michele G, Maltecca F, Carella M, Volpe G, Orio M, et al. (2003) Dementia, ataxia, extrapyramidal features, and epilepsy: phenotype spectrum in two Italian families with spinocerebellar ataxia type 17. Neurol Sci 24: 166-167.
5. Koide R, Kobayashi S, Shimohata T, Ikeuchi T, Maruyama M, et al. (1999) A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? Hum Mol Genet 8: 2047-2053.
6. Stevanin G, Brice A (2008) Spinocerebellar ataxia 17 (SCA17) and Huntington's disease-like 4 (HDL4). Cerebellum 7: 170-178.
7. Rolfs A, Koeppen AH, Bauer I, Bauer P, Buhlmann S, et al. (2003) Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann Neurol 54: 367-375.
8. Bruni AC, Takahashi-Fujigasaki J, Maltecca F, Foncin JF, Servadio A, et al. (2004) Behavioral disorder, dementia, ataxia, and rigidity in a large family with TATA box-binding protein mutation. Arch Neurol 61: 1314-1320.
9. Lasek K, Lencer R, Gaser C, Hagenah J, Walter U, et al. (2006) Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17). Brain 129: 2341-2352.
10. Reetz K, Lencer R, Hagenah JM, Gaser C, Tadic V, et al. (2010) Structural changes associated with progression of motor deficits in spinocerebellar ataxia 17. Cerebellum 9: 210-217.
11. Zuhlke C, Burk K (2007) Spinocerebellar ataxia type 17 is caused by mutations in the TATA-box binding protein. Cerebellum. pp 1-8.
12. Stevanin G, Durr A, Brice A (2000) Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology. Eur J Hum Genet 8: 4-18.
13. Schulz JB, Borkert J, Wolf S, Schmitz-Hubsch T, Rakowicz M, et al. (2010) Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6. Neuroimage 49: 158-168.
14. Onodera O, Idezuka J, Igarashi S, Takiyama Y, Endo K, et al. (1998) Progressive atrophy of cerebellum and brainstem as a function of age and the size of the expanded CAG repeats in the MJD1 gene in Machado-Joseph disease. Ann Neurol 43: 288-296.
15. Klockgether T, Skalej M, Wedekind D, Luft AR, Welte D, et al. (1998) Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. Brain 121 (Pt 9): 1687-1693.
16. Craig K, Keers SM, Walls TJ, Curtis A, Chinnery PF (2005) Minimum prevalence of spinocerebellar ataxia 17 in the north east of England. J Neurol Sci 239: 105-109.
17. Maltecca F, Filla A, Castaldo I, Coppola G, Fragassi NA, et al. (2003) Intergenerational instability and marked anticipation in SCA-17. Neurology 61: 1441-1443.
18. Toyoshima Y, Yamada M, Onodera O, Shimohata M, Inenaga C, et al. (2004) SCA17 homozygote showing Huntington's disease-like phenotype. Ann Neurol 55: 281-286.
19. Netravathi M, Pal PK, Purushottam M, Thennarasu K, Mukherjee M, et al. (2009) Spinocerebellar ataxias types 1, 2 and 3: age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths. J Neurol Sci 277: 83-86.
20. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
21. Helsinki WMADo (2000) Ethical principles for medical research involving human subjects. JAMA 284: 3043-3045.
22. Ashburner J, Friston KJ (2005) Unified segmentation. Neuroimage 26: 839-851.
23. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003) An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19: 1233-1239.